| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2021 | Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis | Bieber, Thomas; Simpson, Eric L; Silverberg, Jonathan I; Thaçi, Diamant; Paul, Carle; Pink, Andrew E; Kataoka, Yoko; CHIA-YU CHU ; DiBonaventura, Marco; Rojo, Ricardo; Antinew, Jeremias; Ionita, Ileana; Sinclair, Rodney; Forman, Seth; Zdybski, Jacek; Biswas, Pinaki; Malhotra, Bimal; Zhang, Fan; Valdez, Hernan | The New England journal of medicine | 143 | 129 | |
| 2021 | Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE | Gooderham, Melinda J; CHIA-YU CHU ; Rojo, Ricardo; Valdez, Hernan; Biswas, Pinaki; Cameron, Michael C; et al., | JAAD international | 8 | 0 |
